Friends of Cancer Research
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$23,104,598
Investments
72%
Other Assets
16%
Cash & Equivalents
7%
Receivables (Non-Related)
5%
Prepaid Expenses
<1%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$4,290,909
Other Liabilities
94%
Payables & Accruals
6%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$663,516
$1,525,764
+130%
Receivables (Non-Related)
$685,666
$1,158,653
+69%
Related-Party Receivables
$0
$0
-
Inventories
$0
$0
-
Prepaid Expenses
$138,892
$130,775
-6%
Investments
$14,484,659
$16,588,415
+15%
Property, Plant, & Equipment (net)
$146,345
$94,929
-35%
Other Assets
$3,544,630
$3,606,062
+2%
Total Assets
$19,663,708
$23,104,598
+17%
Liabilities
2023
2024
Change
Payables & Accruals
$218,632
$237,669
+9%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$3,609,281
$4,053,240
+12%
Total Liabilities
$3,827,913
$4,290,909
+12%
Net assets
2023
2024
Change
Restricted Net Assets
$1,128,750
$1,777,500
+57%
Unrestricted Net Assets
$14,707,045
$17,036,189
+16%
Net assets
2023
2024
Change
Net assets
+$15,835,795
+$18,813,689
+19%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)